Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
PBM stock price ended at $0.67 on 금요일, after rising 0.00%
On the latest trading day Jan 16, 2026, the stock price of PBM rose by 0.00%, climbing from $0.69 to $0.67. Throughout the session, the stock experienced a volatility of 13.11%, with prices fluctuating between a daily low of $0.61 and a high of $0.69. Alongside this price increase, trading volume also rose by 36.7K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 506.8K shares were traded, amounting to a market value of approximately $1.2M.
PBM 기술적 시그널
기술적 시그널 요약
구매 신호 2
중립 신호 1
매도 신호 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
PBM은 현재 2개의 매수 신호와 4개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 --입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
PBM에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 PBM 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.